Tonsillectomy Reduces Recurrence of Streptococcal Pharyngitis in Adults
You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Tonsillectomy Reduces Recurrence of Streptococcal Pharyngitis in Adults

  • Authors: News Author: Laurie Barclay, MD
    CME Author: Charles Vega, MD, FAAFP
  • CME Released: 3/16/2007; Reviewed and Renewed: 3/19/2008
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 3/19/2009, 11:59 PM EST


Target Audience and Goal Statement

This article is intended for primary care clinicians, otolaryngologists, and other specialists who care for adults with recurrent streptococcal pharyngitis.

The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Upon completion of this activity, participants will be able to:

  • Describe previous research into the role of tonsillectomy in preventing streptococcal pharyngitis.
  • Compare tonsillectomy vs control treatment among adults with recurrent streptococcal pharyngitis.


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Laurie Barclay, MD

    Laurie Barclay, MD is a freelance reviewer and writer for Medscape.

    Disclosures

    Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

CME Author(s)

  • Charles P Vega, MD

    Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine

    Disclosures

    Disclosure: Charles Vega, MD, FAAFP, has disclosed that he has received grants for educational activities from Pfizer.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 200 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/06. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity. AAFP credit is subject to change based on topic selection throughout the accreditation year.


    AAFP Accreditation Questions

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME

Tonsillectomy Reduces Recurrence of Streptococcal Pharyngitis in Adults

Authors: News Author: Laurie Barclay, MD CME Author: Charles Vega, MD, FAAFPFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 3/16/2007; Reviewed and Renewed: 3/19/2008

Valid for credit through: 3/19/2009, 11:59 PM EST

processing....

March 16, 2007 — Tonsillectomy reduces further incidence of infection and lessens throat pain in adults with recurrent streptococcal pharyngitis, according to the results of a randomized trial reported in the March 8 Online First issue of the BMJ.

"Traditionally, tonsillectomy has been used to prevent recurrent streptococcal throat infections," write Olli-Pekka Alho, MD, from the University of Oulu in Finland, and colleagues. "Yet according to a recent Cochrane review, there is no empirical evidence to show that it is effective in adults. The exact role played by infection of the palatine tonsils (the tissue removed in tonsillectomy) in streptococcal pharyngitis is unknown, as other pharyngeal lymphoid and soft tissues are often also infected.

At an academic referral center in Finland, 70 adults with documented recurrent episodes of streptococcal group A pharyngitis were randomized to instant tonsillectomy (n = 36) or to remaining on the waiting list (control; n = 34). The primary endpoints were percentage change in the risk for an episode of streptococcal pharyngitis at 90 days, rates of all episodes of pharyngitis, and days with symptoms and adverse effects.

Mean follow-up was 164 ± 63 days in the control group and 170 ± 12 days in the tonsillectomy group. At 90 days, recurrence rate for streptococcal pharyngitis was 24% (8/34) in the control group and 3% (1/36) in the tonsillectomy group (difference, 21%; 95% confidence interval [CI], 6% - 36%). The number needed to treat with tonsillectomy to prevent one recurrence was 5 (95% CI, 3 - 16).

During follow-up, the tonsillectomy group had significantly lower rates of other episodes of pharyngitis and days with throat pain and fever than did the control group. Postoperative throat pain was the most common morbidity related to tonsillectomy (mean length, 13 ± 4 days).

"Adults with a history of documented recurrent episodes of streptococcal pharyngitis were less likely to have further streptococcal or other throat infections or days with throat pain if they had their tonsils removed," the authors write. "According to our results, tonsillectomy is an effective alternative for adults with a documented history of recurrent episodes of pharyngitis."

Study limitations include relatively short follow-up period and possible information bias as throat culture specimens were taken when patients sought medical advice.

"The most common postoperative complications were sore throat and mild bleeding," the authors conclude. "Several other factors, such as risks of anaesthesia, otalgia, fever, dehydration, dental injuries, burns, and soft tissue injuries, have been described. These complaints are usually mild, but a small risk of even life threatening complications exists (recent reported mortality ranging from 1 in 16,000 to 1 in 35,000). Physicians and patients must decide whether these clinical benefits outweigh the risk of further morbidity and the risks involved in the operation."

The study had no external funding, and the authors have disclosed no relevant financial relationships.

BMJ. Published online March 8, 2007.

Clinical Context

Although tonsillectomy is frequently used for recurrent streptococcal pharyngitis, there is some question as to the overall benefit of this procedure. The precise role of the palatine tonsils in recurrent streptococcal pharyngitis is largely unclear, and there are little data regarding the clinical benefits of tonsillectomy for adults with frequent pharyngitis. Research into the practice of using tonsillectomy to prevent recurrent pharyngitis in children has been disappointing, with surgery associated with an average reduction in episodes of sore throat per year of 1.2 and a mean annual reduction in school absence by 2.8 days.

The current study examines the efficacy of tonsillectomy in improving rates of culture-proven streptococcal pharyngitis among a cohort of adults with recurrent pharyngitis.

Study Highlights

  • Patients eligible for study participation were older than 15 years and had experienced 3 or more episodes of pharyngitis in 6 months or 4 episodes in 12 months. Only 1 of these episodes was required to have a positive culture for group A streptococcus. Patients with a history of peritonsillar abscess or with recurrent disease possibly caused by treatment noncompliance were excluded from study participation.
  • Participants were randomized to receive tonsillectomy or to be placed on a surgical waiting list. Tonsillectomy was performed an average of 13 days following randomization into the surgery cohort.
  • The main study outcome was the rate of culture-confirmed group A streptococcal pharyngeal infection within 90 days of follow-up. To gather this data, patients were encouraged to visit their primary care clinicians for symptoms of pharyngitis. Researchers also followed total episodes of pharyngitis, defined as 2 consecutive days of sore throat symptoms.
  • 70 subjects enrolled in the trial. Baseline data were similar between the surgery and control groups. The mean age was 26 years old, and the mean number of episodes of acute pharyngitis was 3.4 in the previous 6 months. 13% of participants had evidence of chronically infected tonsils, and three quarters of the cohort had evidence of tonsillar scarring.
  • Rates of sampling for streptococcal pharyngitis within the first 90 days were 20 in the control group and 5 in the surgery group. The respective numbers of positive cultures were 8 and 1 (difference in rates of culture-confirmed streptococcal pharyngitis, 21%). Generally, subjects in the control group also experienced a faster time to the first episode of pharyngitis.
  • Rates of pharyngitis associated with medical consultation were 41% and 11% in the control and tonsillectomy groups, respectively, whereas the respective rates for any pharyngitis were 56% and 31%.
  • Tonsillectomy incurred an average of 1 hour of time in the operating department, 1 day of hospital admission, and 13 days of throat pain following surgery. There were no major adverse events associated with tonsillectomy, and 2 subjects experienced minor bleeding after surgery.

Pearls for Practice

  • Previous research has not confirmed the precise role of the palatine tonsils in recurrent streptococcal pharyngitis, and there have been few studies focused on the role of tonsillectomy for this indication in adults. Tonsillectomy appears to be only mildly beneficial for recurrent pharyngitis in children.
  • The current study demonstrates that tonsillectomy improves rates of streptococcal pharyngitis and any pharyngitis in the first 3 months following surgery on adults with recurrent pharyngitis. Tonsillectomy was associated with 13 days of postoperative throat pain and no major adverse events.

CME Test

  • Print